Google Alert - hepatitis c

[Guest guest]

News

10 new results for hepatitis c

Abbott Receives FDA Approval for Molecular Test for Hepatitis CPharmaLive.com (press release)... 2011 /PRNewswire via COMTEX/ --Abbott (NYSE: ABT) announced today that it has received approval from the US Food and Drug Administration to market its RealTime PCR (polymerase chain reaction) test for measuring the viral load of hepatitis C (HCV), ...See all stories on this topic »

Merck's Hepatitis C Drug Wins FDA ApprovalTheBody.comThe Food and Drug Administration on Friday approved Merck's new hepatitis C virus drug Victrelis (boceprevir), which shortens the treatment time for some patients. Two-thirds of HCV patients in clinical trials achieved a sustained viral response on ...See all stories on this topic »

Higher Rebates and Discounts Have Greater Influence on Reimbursement Status ...EON: Enhanced Online News (press release)According to the recent Formulary Forum report entitled Formulary Advantages in Hepatitis C: Despite the Near Certainty of Emerging Oral Protease Inhibitors, Pharmacy Directors Remain Unsure of the Value and Reimbursement Status of Triple Therapy ...See all stories on this topic »

Hepatitis C, African Americans, and INCIVEKSan Francisco Chronicle (blog)Hepatitis C is a viral infection that causes swelling and infection of the liver, and is particularly active within the African American Community, and at a level called "chronic," representing 22 percent of all known carriers in America. ...See all stories on this topic »

San Francisco Chronicle (blog)

Shock results in liver study testsBlackpool GazetteBy Emma MORE work is to be carried out to tackle hepatitis C in Blackpool after two thirds of those tested in a study were found to have the disease. The resort was chosen for the British Liver Trust pilot scheme because it has the worst rates ...See all stories on this topic »

Blackpool Gazette

Merck, Roche team up on hepatitis C drugsArizona Daily StarTRENTON, NJ - After a decade as rivals, drug makers Merck & Co. and Roche are teaming up to market their hepatitis C medicines just as drugs from a new class are about to transform treatment of the tough-to-cure virus. Merck's Victrelis, approved last ...See all stories on this topic »

Rising Prevalence of Hepatitis C Driving Russian Pharma MarketIndustry Today (press release)Alarming number of Hepatitis C patients in Russia is anticipated to drive the nation's pharmaceutical industry in the coming years, says RNCOS in its latest research study. Posted via Industry Today. Are you into it? Follow us on Twitter @IndustryToday ...See all stories on this topic »

Review of needs to include whether home help required Concern at plans for ...Irish TimesVICTIMS OF the hepatitis C blood contamination scandal are concerned at plans by the Health Service Executive to conduct a fresh assessment of their needs, including a review of whether or not they need home help. A range of benefits has been provided ...See all stories on this topic »

Al-Sayer lunches 'HepCare' free treatment for employeesKuwait TimesPeople infected with hepatitis virus can sometimes appear to having no signs at all, but the fact is they are active carrier of the virus," he added. Al-Enezi mentioned that hepatitis B is a curable disease while hepatitis C vaccine are yet to be ...See all stories on this topic »

Three Rivers Pharmaceuticals package wins compliance awardHealthcare PackagingMedical literature indicates that adherence to ribavirin therapy is correlated with improved sustained viral response and reduced risk of relapse in the treatment of adults with chronic Hepatitis C. With Ribasphere® RibaPak, patients take only two ...See all stories on this topic »

Healthcare Packaging